 | |
 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Elimination half-life | 50 h |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard ( EPA) | |
| ECHA InfoCard | 100.057.776 |
| Chemical and physical data | |
| Formula | C19H19FN2O |
| Molar mass | 310.372 g·mol−1 |
| 3D model ( JSmol) | |
| |
| |
 
(what is this?)
(verify) | |
Desmethylcitalopram is an active metabolite of the antidepressant drugs citalopram ( racemic) and escitalopram (the S- enantiomer, which would be called desmethylescitalopram). [1] [2] Like citalopram and escitalopram, desmethylcitalopram functions as a selective serotonin reuptake inhibitor (SSRI), and is responsible for some of its parents' therapeutic benefits.
See also
References
- ^ "Desmethylcitalopram". Human Metabolome Database.
- ^ Brøsen K, Naranjo CA (August 2001). "Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram". European Neuropsychopharmacology. 11 (4): 275–83. doi: 10.1016/s0924-977x(01)00101-8. PMID 11532381. S2CID 11837037.
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
|
| |
|
| |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Elimination half-life | 50 h |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard ( EPA) | |
| ECHA InfoCard | 100.057.776 |
| Chemical and physical data | |
| Formula | C19H19FN2O |
| Molar mass | 310.372 g·mol−1 |
| 3D model ( JSmol) | |
| |
| |
|
(what is this?)
(verify) | |
Desmethylcitalopram is an active metabolite of the antidepressant drugs citalopram ( racemic) and escitalopram (the S- enantiomer, which would be called desmethylescitalopram). [1] [2] Like citalopram and escitalopram, desmethylcitalopram functions as a selective serotonin reuptake inhibitor (SSRI), and is responsible for some of its parents' therapeutic benefits.
See also
References
- ^ "Desmethylcitalopram". Human Metabolome Database.
- ^ Brøsen K, Naranjo CA (August 2001). "Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram". European Neuropsychopharmacology. 11 (4): 275–83. doi: 10.1016/s0924-977x(01)00101-8. PMID 11532381. S2CID 11837037.
|
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |